OPTIMIZE Sirolimus-Eluting Coronary Stent Systems Pharmacokinetics (PK) Study

Inclusion Criteria: * Subject is an eligible candidate for PCI * Subject has symptomatic coronary artery disease with objective evidence of ischemia or silent ischemia * Subject is an acceptable candidate for CABG * Subject has ≤ 3 de novo target lesions in ≤ 2 native coronary artery vessels, with ≤ 2 lesions in a single vessel, each meeting the angiographic criteria and none of the exclusion criteria * Target lesion(s) must be located in a native coronary artery with RVD ≥ 2.25mm and ≤ 4.00mm Exclusion Criteria: * Subject has cardiogenic shock, hemodynamic instability requiring inotropic or mechanical circulatory support, intractable ventricular arrhythmia, or ongoing intractable angina * Subject's target lesion(s) is located in the left main coronary artery * Subject's target lesion(s) is located within 3mm of the origin of the LAD or LCX coronary artery * Subject's target lesion(s) is located within a SVG or an arterial graft * Subject's target lesion(s) will be accessed via SVG or arterial graft